China is not as big a player in the manufacturing of key ingredients used to make brand and generic medicines as previously ...

Play the USA TODAY Daily Crossword Puzzle. Tesla's battery-electric vehicle (BEV) registrations in 25 European Union markets, the UK, Norway and Switzerland fell on average by 44% from the same ...

The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for ...

The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than ...

CHMP reversed its initial recommendation for the EC to not authorize the drug due to the risk of side effects like ARIA.

Eisai and Biogen can finally put their European regulatory uncertainty surrounding Alzheimer's disease medicine Leqembi ...

Cullinan Therapeutics (CGEM) announced that the European Medicines Agency, EMA, approved the Company’s Clinical Trial Application, CTA, for ...

The antibody lecanemab is the first authorized therapy in Europe that targets the underlying process of Alzheimer's, rather than only treating symptoms.

Supplements, especially in pill form, usually contain some type of bulking agent or filler to help achieve a uniform shape ...

South Africa's application forms part of a joint review by the European Medicines Agency, WHO and our medicines regulator, ...

Telangana: Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the ...

A key theme at the AD/PD 2025 has been the safety profile of DMTs, focusing on the issue of ARIA, a significant side effect ...